Notice of preliminary results

London, February 8, 2022 – Hikma Pharmaceuticals PLC (Hikma, Group), will announce its preliminary financial results for the year ended 31 December 2021 on Thursday 24 February 2022.

Press Release Corporate 8 February 2022

A recording of the presentation will be available on the Group’s website at from 7:00am GMT. Hikma will also hold a live Q&A conference call for analysts at 9:30am GMT, and a recording will be made available on the Company’s website.

To join via conference call please dial:

United Kingdom: 0800 640 6441

United Kingdom (local): 020 3936 2999

All other locations: +44 20 3936 2999

Access code: 446040

For further information please contact Tiina Lugmayer –

Important notice for users

You are about to access Hikma historic archive material. Any reference in these archives to Hikma products or their uses may not reflect current medical knowledge and should not be used as a source of information on the present product label, efficacy data, or safety data. Please refer to your approved national product label (SmPC) for current product information.

I have read this warning and will not be using any of the contained product information for clinical purposes.